HHS Secretary nominee Robert F. Kennedy Jr. will divest his interests in several biopharma companies, including CRISPR ...

Thermo Fisher Scientific should be safe. RFK Jr. may disrupt Big Pharma, but he’s unlikely to cause research to completely ...

Don Dempsey reportedly in frame to serve as Office of Management and Budget’s leading health offical, a role that would hand him sweeping powers to rein in Kennedy’s ambitions ...

Editorial page editor Jim Dao sits down with Globe Opinion columnist Joan Vennochi and Globe political reporter James Pindell ...

President Donald Trump made good on his campaign promises to kick off his second term in office with a tidal wave of ...

Following his win over Kamala Harris, Donald Trump has been assembling the administration for his second term in the White ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

Restored to power, President Trump claimed that God put him there and asserted the right to single-handedly redraw the world ...

Robert Lighthizer, the former U.S. Trade Representative, lost his bid to rejoin the White House, but he still believes the ...

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

In his inaugural address, President Donald Trump promised to reform the public health system and reverse actions taken ...

Jon Hochschartner Anyone who cares about animals should oppose Robert F. Kennedy Jr., President-Elect Donald Trump’s nominee for secretary of Health and Human Services. Available evidence suggests he ...